Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ARS Pharmaceuticals, Inc. (SPRY) vs Turn Therapeutics Inc. (TTRX)

ARS Pharmaceuticals, Inc. and Turn Therapeutics Inc. are both Biotechnology companies. ARS Pharmaceuticals, Inc. and Turn Therapeutics Inc. are of similar size ($412.7M and $395.0M). Turn Therapeutics Inc. has the higher net margin (0.00% vs −184.3%) and the higher return on invested capital (0.00% vs −335.7%). Across the 13 metrics below, Turn Therapeutics Inc. leads on 8 and ARS Pharmaceuticals, Inc. on 5.

Valuation

Metric SPRY TTRX Biotechnology median
P/E n/m n/m 7.88
P/S 3.47 n/m 11.47
P/B 32.38 533.83 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 3.70 n/m 10.73
Earnings yield (53.43%) (2.36%) (28.84%)
Free cash flow yield (52.35%) (1.22%) (23.03%)

Profitability

Metric SPRY TTRX Biotechnology median
Gross margin 71.37% — 65.16%
Operating margin (184.96%) 0.00% 0.00%
Net margin (184.26%) 0.00% 0.00%
Free cash flow margin (167.97%) 0.00% 0.00%
Return on equity (210.37%) (3,315.33%) (57.72%)
Return on assets (76.54%) (99.59%) (49.22%)
Return on invested capital (335.65%) 0.00% 0.00%

Growth

Metric SPRY TTRX Biotechnology median
Revenue growth (TTM) 4.08% — 5.64%
EPS growth (last fiscal year) (2,275.00%) (80.72%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric SPRY TTRX Biotechnology median
Debt to equity 13.72 8.83 0.00
Current ratio 3.48 1.19 4.73
Net debt to EBITDA 0.42 0.96 0.96

Dividend

Metric SPRY TTRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric SPRY TTRX Biotechnology median
Market cap 412.71m 394.99m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack